1. Home
  2. CLNE vs QTTB Comparison

CLNE vs QTTB Comparison

Compare CLNE & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Fuels Corp.

CLNE

Clean Energy Fuels Corp.

N/A

Current Price

$1.47

Market Cap

447.1M

Sector

Utilities

ML Signal

N/A

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

N/A

Current Price

$8.32

Market Cap

450.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLNE
QTTB
Founded
2001
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Natural Gas Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
447.1M
450.1M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
CLNE
QTTB
Price
$1.47
$8.32
Analyst Decision
Buy
Strong Buy
Analyst Count
6
6
Target Price
$4.01
★ $39.60
AVG Volume (30 Days)
★ 1.2M
827.2K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 136.78
EPS
★ N/A
N/A
Revenue
★ $341,599,000.00
$53,737,000.00
Revenue This Year
$1.41
N/A
Revenue Next Year
$2.08
$150.00
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.52
$1.91
52 Week High
$3.11
$23.57

Technical Indicators

Market Signals
Indicator
CLNE
QTTB
Relative Strength Index (RSI) 32.46 30.86
Support Level N/A $5.12
Resistance Level $1.84 $16.85
Average True Range (ATR) 0.04 0.70
MACD -0.01 0.07
Stochastic Oscillator 1.85 22.26

Price Performance

Historical Comparison
CLNE
QTTB

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas and liquefied natural gas for the United States (U.S.) and Canadian transportation markets. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The firm operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. It also builds, operates, and maintains natural gas fueling stations for customers.

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).

Share on Social Networks: